<DOC>
	<DOCNO>NCT02680301</DOCNO>
	<brief_summary>The purpose study 1 . Compare efficacy 0.1 % triamcinolone contain wet wrap ointment cream formulation patient moderate severe atopic dermatitis 2 . The relative patient/subject acceptance adherence also compare two wet wrap type</brief_summary>
	<brief_title>Topical Steroid Formulation Wet Wraps</brief_title>
	<detailed_description>In study , investigator examine effectiveness wet wrap topical steroid different formulation patient history atopic dermatitis experience acute flare . A validated clinical tool Investigator 's Global Assessment ( IGA ) use order ass severity condition well demonstrate appropriateness use wet wrap therapy treatment modality . IGA measure intensity atopic dermatitis regard erythema , lichenification , swell excoriation well subjective symptom patient numeric scale . The treat clinician ask rate assessment therapy . Patients ask apply topical steroid cream formulation one extremity apply topical steroid ointment formulation use wet wrap technique . One investigator nursing staff provide detailed instruction patient parent perform wet dress ( already routinely do patient initiate wet wrap therapy pediatric dermatology clinic ) . Patients also give seal cod envelope contain instruction apply one steroid formulation right extremity leave . In manner provider blind treatment modality follow-up visit . Only research coordinator access envelope code key . An additional handout also provide reinforce appropriate treatment technique . After several day ( 3-5 ) patient return dermatology clinic nurse visit evaluation improvement affect area well comparison improvement right leave extremity . The physician investigator examine patient measure improvement use IGA . Detailed photo affect area also take . After certain number patient enrol study complete , de-identified data examine statistician comparison . Other study evaluate effectiveness wet wrap commonly 40-50 patient enrol likely target study . The statistician compare IGA treatment side allow interpretation data . Stratification data may include age and/or severity ( moderate v severe ) . Patient Oriented Eczema Measure ( POEM ) and/or Quality Life ( QoL ) index also provide determine patient 's point view regard management use validated tool . They also ask opinion regard one side well control , , well personal preference treatment choice . Compliance determine weigh medication visit medication calendar .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>1 . Patients age 317 experience symmetric , bilateral flare atopic dermatitis 2 . The flare must reach certain threshold inclusion base investigator 's global assessment scale 1 . Systemic infection bacterial skin infection 2 . Eczema herpeticum 3 . Evidence suppression HypothalamicPituitaryAdrenal axis 4 . NonEnglish NonSpanish speaking</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Wet Wraps</keyword>
	<keyword>Topical Steroid</keyword>
</DOC>